Showing results (11-20 of 141) with videos related to
Sort By:
Pageof 15
Pharmacology & Therapeutics|September 21, 2024
Opportunities and challenges in the therapeutic exploitation of histamine and histamine receptor pharmacology in inflammation-driven disordersEkaterini Tiligada, Charikleia Stefanaki, Madeleine Ennis, et al.International Immunopharmacology|April 9, 2013
Seasonal influence on mitogen and cyclosporin responses of peripheral blood lymphocytesFotios V Michelis, Andreas K Delitheos, Ekaterini TiligadaJournal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|April 20, 2011
Effect of aminoguanidine on the conjunctival histamine and nitrite levels in experimental conjunctivitisMiltiadis Papathanassiou, Vasiliki Giannoulaki, Evangelia Zampeli, et al.The Biochemical Journal|October 16, 2008
Extracellular Ca2+ transients affect poly-(R)-3-hydroxybutyrate regulation by the AtoS-AtoC system in Escherichia coliMarina C Theodorou, Ekaterini Tiligada, Dimitrios A KyriakidisInflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|June 1, 2022
Histamine research advancements in the second year of the COVID-19 pandemic: report of the European Histamine Research Society (EHRS)Ilona Obara, João Paulo S Fernandes, Ekaterini TiligadaExpert Opinion on Investigational Drugs|September 18, 2009
Histamine H3 and H4 receptors as novel drug targetsEkaterini Tiligada, Evangelia Zampeli, Kerstin Sander, et al.Frontiers in Bioscience (Landmark Edition)|December 29, 2011
Histamine in two component system-mediated bacterial signalingDimitrios A Kyriakidis, Marina C Theodorou, Ekaterini TiligadaEuropean Journal of Pharmacology|November 26, 2003
Nadroparine inhibits the hypersensitivity response in the conjunctivaVassiliki Giannoulaki, Miltiades Papathanassiou, Nikolaos M Sitaras, et al.World Journal of Gastroenterology|May 7, 2015
Withdrawal of anti-tumour necrosis factor α therapy in inflammatory bowel diseaseKonstantinos Papamichael, Severine VermeireCNS Neuroscience & Therapeutics|November 11, 2011
Histamine pharmacology and new CNS drug targetsEkaterini Tiligada, Konstantinos Kyriakidis, Paul L Chazot, et al.Pageof 15